AR018313A1 - Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo - Google Patents
Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivoInfo
- Publication number
- AR018313A1 AR018313A1 ARP990100933A ARP990100933A AR018313A1 AR 018313 A1 AR018313 A1 AR 018313A1 AR P990100933 A ARP990100933 A AR P990100933A AR P990100933 A ARP990100933 A AR P990100933A AR 018313 A1 AR018313 A1 AR 018313A1
- Authority
- AR
- Argentina
- Prior art keywords
- conceptive
- agent
- profile
- progestagenic
- kit
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Un kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, donde el agente anticonceptivo unico es uncompuesto esteroide que tiene un perfil de actividad que combina inherentemente las actividades progestagénicas y estrogénica. Dentro de una clasegeneral de compuestos esteroidales conocidos, se han encontrado esteroides que tienen un perfil combinado destacado de propiedades biologicas para eluso en la anticoncepcion, especialmente por monoterapia. Estos esteroides se seleccionan del grupo que consiste en esteroides que satisfacen la formulaestructural (I) y prodrogas de los mismos, donde cada una de la líneas punteadas indica independientemente un enlace adicional opcional.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98200744 | 1998-03-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR018313A1 true AR018313A1 (es) | 2001-11-14 |
Family
ID=8233452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100933A AR018313A1 (es) | 1998-03-09 | 1999-03-05 | Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1061928A2 (es) |
| JP (1) | JP2002506014A (es) |
| KR (1) | KR20010041698A (es) |
| CN (1) | CN1292702A (es) |
| AR (1) | AR018313A1 (es) |
| AU (1) | AU756882B2 (es) |
| BR (1) | BR9908605A (es) |
| CA (1) | CA2319765A1 (es) |
| CO (1) | CO5070598A1 (es) |
| HU (1) | HUP0101007A3 (es) |
| ID (1) | ID25621A (es) |
| IL (1) | IL137541A0 (es) |
| NO (1) | NO20004492D0 (es) |
| NZ (1) | NZ506115A (es) |
| PE (1) | PE20000330A1 (es) |
| PL (1) | PL343428A1 (es) |
| RU (1) | RU2225714C2 (es) |
| TR (1) | TR200002593T2 (es) |
| WO (1) | WO1999045886A2 (es) |
| ZA (1) | ZA991851B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999051214A2 (en) * | 1998-04-07 | 1999-10-14 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
| BR0013769A (pt) * | 1999-09-06 | 2002-04-30 | Akzo Nobel Nv | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide |
| ES2241854T3 (es) | 2000-07-28 | 2005-11-01 | Akzo Nobel N.V. | Estrogenos de sustitucion metilo o etilo en posicion 16 alfa. |
| CA2478206A1 (en) * | 2002-03-11 | 2003-09-25 | Patrick Michel Caubel | Sulfatase inhibiting continuous progestogen contraceptive regimens |
| US20030225047A1 (en) * | 2002-03-11 | 2003-12-04 | Caubel Patrick Michel | Sulfatase inhibiting progestogen-only contraceptive regimens |
| UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7701384A (nl) * | 1977-02-10 | 1978-08-14 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks. |
| DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
| ZA94715B (en) * | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
-
1999
- 1999-03-03 WO PCT/EP1999/001404 patent/WO1999045886A2/en not_active Ceased
- 1999-03-03 TR TR2000/02593T patent/TR200002593T2/xx unknown
- 1999-03-03 ID IDW20001715A patent/ID25621A/id unknown
- 1999-03-03 HU HU0101007A patent/HUP0101007A3/hu unknown
- 1999-03-03 IL IL13754199A patent/IL137541A0/xx unknown
- 1999-03-03 RU RU2000125572/15A patent/RU2225714C2/ru not_active IP Right Cessation
- 1999-03-03 EP EP99939157A patent/EP1061928A2/en not_active Withdrawn
- 1999-03-03 AU AU31437/99A patent/AU756882B2/en not_active Ceased
- 1999-03-03 CN CN998037710A patent/CN1292702A/zh active Pending
- 1999-03-03 BR BR9908605-0A patent/BR9908605A/pt not_active IP Right Cessation
- 1999-03-03 NZ NZ506115A patent/NZ506115A/en unknown
- 1999-03-03 KR KR1020007009917A patent/KR20010041698A/ko not_active Ceased
- 1999-03-03 PL PL99343428A patent/PL343428A1/xx unknown
- 1999-03-03 JP JP2000535302A patent/JP2002506014A/ja not_active Withdrawn
- 1999-03-03 CA CA002319765A patent/CA2319765A1/en not_active Abandoned
- 1999-03-05 AR ARP990100933A patent/AR018313A1/es not_active Application Discontinuation
- 1999-03-08 CO CO99014138A patent/CO5070598A1/es unknown
- 1999-03-08 ZA ZA9901851A patent/ZA991851B/xx unknown
- 1999-03-09 PE PE1999000186A patent/PE20000330A1/es not_active Application Discontinuation
-
2000
- 2000-09-08 NO NO20004492A patent/NO20004492D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20000330A1 (es) | 2000-05-16 |
| JP2002506014A (ja) | 2002-02-26 |
| TR200002593T2 (tr) | 2000-12-21 |
| PL343428A1 (en) | 2001-08-13 |
| NO20004492L (no) | 2000-09-08 |
| NO20004492D0 (no) | 2000-09-08 |
| NZ506115A (en) | 2003-07-25 |
| AU756882B2 (en) | 2003-01-23 |
| EP1061928A2 (en) | 2000-12-27 |
| IL137541A0 (en) | 2001-07-24 |
| CN1292702A (zh) | 2001-04-25 |
| HUP0101007A2 (hu) | 2001-12-28 |
| CA2319765A1 (en) | 1999-09-16 |
| ZA991851B (en) | 1999-09-22 |
| WO1999045886A3 (en) | 1999-12-02 |
| KR20010041698A (ko) | 2001-05-25 |
| WO1999045886A2 (en) | 1999-09-16 |
| BR9908605A (pt) | 2001-04-24 |
| AU3143799A (en) | 1999-09-27 |
| CO5070598A1 (es) | 2001-08-28 |
| RU2225714C2 (ru) | 2004-03-20 |
| HUP0101007A3 (en) | 2002-02-28 |
| ID25621A (id) | 2000-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0517752A (pt) | processo para a preparação de drospirenona | |
| ES2174629T3 (es) | 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos. | |
| CR7420A (es) | Composiciones farmaceuticas que comprenden uno o varios esteroides, uno o varios componentes de tetrahiidrofolatos y vitamina b12 | |
| DK1272504T3 (da) | 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener | |
| TR200002774T2 (tr) | Alzheimer hastalığının tedavisi için steroit sapogenler ve bunların türevleri | |
| ES2191320T3 (es) | Derivados de piperazina y su uso como agentes anti-inflamatorios. | |
| AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
| AR011480A1 (es) | ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA. | |
| EA200601648A1 (ru) | Глюкозамин и общие пролекарства глюкозамин/противовоспалительный агент, композиции и способы | |
| BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
| AR046671A1 (es) | Uso extendido de combinacion que comprende estrogenos y progestinas | |
| ES2196063T3 (es) | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| ECSP084358A (es) | NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA | |
| BRPI0512993A (pt) | uso de um antagonista de pr, kit farmaceuticamente últil, e, método de contracepção em uma fêmea em idade de parto | |
| AR040130A1 (es) | Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos | |
| AR018313A1 (es) | Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo | |
| CY1110173T1 (el) | Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης | |
| AR026655A1 (es) | Nuevos esteroides con actividad androgenica y su uso como antinconceptivos masculinos y para tratar la insuficiencia androgenica | |
| AR046672A1 (es) | Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol | |
| BR0013769A (pt) | Esteróides estrogênicos não aromáticos, composição farmacêutica, e, uso de um composto esteróide | |
| AR040188A1 (es) | Estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva | |
| PA8633601A1 (es) | Profarmacos de esteroides con accion androgenica | |
| ATE419855T1 (de) | Therapie für hormonersatz und depression enthaltend dienogest | |
| TW200612962A (en) | Estriol and estetrol prodrugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |